OPS
EWTX icon

Orion Portfolio Solutions’s Edgewise Therapeutics EWTX Stock Holding History

Orion Portfolio Solutions’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$256K Sell
11,633
-295
-2% -$7.74K ﹤0.01% 1696
2024
Q4 		$318K Sell
11,928
-1,083
-8% -$34.5K ﹤0.01% 1532
2024
Q3 		$347K Buy
+13,011
New +$259K ﹤0.01% 1471

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Orion Portfolio Solutions's EWTX Position: Q1 2025 in Review

Orion Portfolio Solutions reduced its Edgewise Therapeutics (EWTX) stake by 2.5% in Q1 2025, selling an estimated $7.74K and leaving 11,633 shares worth $256K. The position accounts for ﹤0.01% of the portfolio, ranked #1696.

Orion Portfolio Solutions first reported a position in EWTX in Q3 2024 and has held it in 3 quarters since. The position peaked at $347K in Q3 2024. 192 funds tracked by Wall St. Rank hold EWTX as of Q1 2025.

  • Orion Portfolio Solutions held 11,633 shares of Edgewise Therapeutics worth $256K as of Q1 2025.
  • Orion Portfolio Solutions sold 295 Edgewise Therapeutics shares in Q1 2025, an estimated $7.74K.
  • Edgewise Therapeutics made up ﹤0.01% of Orion Portfolio Solutions's portfolio in Q1 2025, its #1696 holding.
  • Orion Portfolio Solutions first reported a position in Edgewise Therapeutics in Q3 2024 and has held it in 3 quarters since.
  • Orion Portfolio Solutions's Edgewise Therapeutics position peaked at $347K in Q3 2024.
  • 192 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.